Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/jcp.25043 http://scihub22266oqcxt.onion/10.1002/jcp.25043 C4811601!4811601!25975415     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Cell+Physiol 2015 ; 230 (12): 2891-7 Nephropedia Template TP {{tp|p=25975415|t=2015. The Many Faces of the A2b Adenosine Receptor in Cardiovascular and Metabolic Diseases |pdf=|usr=}}{{25975415}} gab.com Text The Many Faces of the A2b Adenosine Receptor in Cardiovascular and Metabolic Diseases JO: J Cell Physiol http://www.kidney.de/pget.php?&tw=1&pmid=25975415 #FOAvip Modulation of the low affinity adenosine receptor subtype, the A2b adenosine receptor (A2bAR), has gained interest as a therapeutic target in various pathologic areas associated with cardiovascular disease. The actions of the A2bAR are diverse and at times conflicting depending on cell and tissue type and the timing of activation or inhibition of the receptor. The A2bAR is a promising and exciting pharmacologic target, however, a thorough understanding of A2bAR action is necessary to reach the therapeutic potential of this receptor. This review will focus on the role of the A2bAR in various cardiovascular and metabolic pathologies in which the receptor is currently being studied. We will illustrate the complexities of A2bAR signaling and highlight areas of research with potential for therapeutic development. Twit Text FOAVip The Many Faces of the A2b Adenosine Receptor in Cardiovascular and Metabolic Diseases ????J Cell Physiol http://www.kidney.de/pget.php?&tw=1&pmid=25975415 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25975415 #FOAvip English Wikipedia <ref>{{Cite pmid|25975415}}</ref> The Many Faces of the A2b Adenosine Receptor in Cardiovascular and Metabolic Diseases #MMPMID25975415 Eisenstein A; Patterson S; Ravid K J Cell Physiol 2015[Dec]; 230 (12): 2891-7 PMID25975415show ga Modulation of the low affinity adenosine receptor subtype, the A2b adenosine receptor (A2bAR), has gained interest as a therapeutic target in various pathologic areas associated with cardiovascular disease. The actions of the A2bAR are diverse and at times conflicting depending on cell and tissue type and the timing of activation or inhibition of the receptor. The A2bAR is a promising and exciting pharmacologic target, however, a thorough understanding of A2bAR action is necessary to reach the therapeutic potential of this receptor. This review will focus on the role of the A2bAR in various cardiovascular and metabolic pathologies in which the receptor is currently being studied. We will illustrate the complexities of A2bAR signaling and highlight areas of research with potential for therapeutic development. äThe Many Faces of the A2b Adenosine Receptor in Cardiovascular and Met(epmc).pdf DeepDyve Pubget Overpricing